Atlas Trials

Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes

Clinical trial NCT02932826 · UNKNOWN

Trial details

NCT number
NCT02932826
Sponsor
Second Xiangya Hospital of Central South University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2016-10-01
Primary completion
2025-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.